0

Oritavancin diphosphate

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP192564140
CAS192564-14-0
Structure
Molecular Weight1989.09
Description≥97% (HPLC)
SolubilityH2O: 10 mg/mL, clear
Assay≥97% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

Dalbavancin

Dennis J Cada, Kyle Ingram, Danial E Baker

Hosp Pharm. 2014 Oct;49(9):851-61.

PMID: 25477617

1

Dalbavancin, Tedizolid Phosphate, Oritavancin Diphosphate, and Vedolizumab

Daniel A Hussar, Angelique Nguyen

J Am Pharm Assoc (2003). Nov-Dec 2014;54(6):658-62.

PMID: 25379985

1

Oritavancin Diphosphate

Dennis J Cada, Danial E Baker

Hosp Pharm. 2014 Dec;49(11):1049-60.

PMID: 25673895

1

Visual Compatibility of Oritavancin Diphosphate With Selected Coadministered Drugs During Simulated Y-site Administration

Atul Kumar, Henry J Mann

Am J Health Syst Pharm. 2010 Oct 1;67(19):1640-4.

PMID: 20852166

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode